Lajme nga Bota

Oxford vaccine up to 70% effective from Covid-19, but cheaper and easier to maintain

Oxford vaccine up to 70% effective from Covid-19, but cheaper and easier to

The coronavirus vaccine developed by the University of Oxford provides 70% protection against Covid-19 infection.

However, studies conducted so far are not conclusive and there are data that show that if the vaccine dose is further improved, the protection goes up to 90%.

The results are seen as a triumph and a disappointment as the Pfizer and Moderna vaccines showed 95% protection.

However, the Oxford vaccine is much cheaper and easier to maintain and reach in every corner of the world than the other two.

So the vaccine will play an important role in treating the pandemic, if approved for use.

"The announcement today brings us one step closer to the time when we can use vaccines to end the destruction caused by the virus," said vaccine architect Prof. Sarah Gilbert.

Oxford vaccine up to 70% effective from Covid-19, but cheaper and easier to

The UK government has pre-ordered 100 million doses of the Oxford and AstraZeneca vaccine, enough to immunize 50 million people. While it is said that three billion doses will be prepared for the world next year.

Prime Minister Boris Johnson has described this as "extremely exciting news and fantastic results".

Prof. Andreë Pollard, drejtuesi kryesor i provave u shpreh se “Ne jemi vërtet të kënaqur me këto rezultate”. Ai tha se të dhënat e efektivitetit 90% ishin “intriguese” dhe do të thoshin se “ne do të kishim shumë më shumë doza për të shpërndarë”.
Kishte gjithashtu nivele më të ulëta të infeksionit asimptomatik në grupin e ulët të ndjekur nga doza të larta që “do të thotë që ne mund të jemi në gjendje të ndalojmë virusin në gjurmët e tij”, tha Prof Pollard.

Oxford vaccine up to 70% effective from Covid-19, but cheaper and easier to

Sidoqoftë, Mbretëria e Bashkuar është e gatshme të shtyp butonin ‘shko’ në një fushatë të paparë të imunizimit masiv me programet vjetore të gripit ose të vaksinimit të fëmijëve.

The Oxford vaccine has essential advantages that make it easier to use. It can be stored at refrigerator temperature, which means it can be distributed in any corner of the world, unlike the Pfizer / BioNTech and Moderna vaccines, which need to be stored at much colder temperatures.

The Oxford vaccine is expected to be priced at around £ 3, much less than the Pfizer (15 15) or Moderna (£ 25) vaccines.

* Article taken from the BBC. Translated and adapted for Tiranapost.al.